News & Updates

Esketamine outperforms quetiapine in head-to-head depression trial
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023 byJairia Dela Cruz

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023